Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targetsXiangyuan Luo, Xingxing He|Journal of Experimental & Clinical Cancer Research|2021Cited by 216
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transitionXiangyuan Luo, Xingxing He|Experimental Hematology and Oncology|2021Cited by 101
Persistent Effect of IFNAR-1 Genetic Polymorphism on the Long-Term Pathogenesis of Chronic HBV InfectionXingxing He, Ju‐Sheng Lin, Huajun Jiang et al.|Viral Immunology|2010Cited by 38
Autophagy inhibition enhanced 5‑FU‑induced cell death in human gastric carcinoma BGC‑823 cellsXingxing He, Bu‐Shan Xie|Molecular Medicine Reports|2018Cited by 22